NCT02930005View on ClinicalTrials.gov

Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 7, 2015

Primary Completion Date

October 6, 2016

Study Completion Date

October 6, 2016

Conditions
Psychotic DisordersSchizophreniaSchizoaffective DisorderBipolar Disorder
Interventions
DRUG

Meclofenamic acid

DRUG

Pentosan polysulfate sodium

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02930005 - Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders | Biotech Hunter | Biotech Hunter